Prophylaxis and treatment of gastrointestinal complications following transplantation
- 1 August 2001
- journal article
- review article
- Published by Wiley in Clinical Transplantation
- Vol. 15 (s4) , 29-35
- https://doi.org/10.1111/j.1399-0012.2001.00029.x
Abstract
Most transplant recipients will experience some type of gastrointestinal (GI) complication. These effects often are caused by infectious damage induced by a variety of opportunistic organisms, but they also may be due to mechanical injury during surgery or to metabolic or organ toxicity associated with immunosuppressive regimens. Although some of these GI complications can substantially impair quality of life or even carry significant mortality risk, many of them can be prevented, and most of them can be treated medically without the need to stop immunosuppression and expose the patient to the risk of rejection. Limiting the use of steroids, giving prophylactic antiviral and antifungal agents (particularly to patients at risk) and adopting a low threshold for endoscopy are among the most important measures that can be used to avoid GI complications after transplantation.Keywords
This publication has 38 references indexed in Scilit:
- Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal TransplantationNew England Journal of Medicine, 1999
- Mycophenolate mofetil, microemulsion cyclosporine, and prednisone as primary immunosuppression for pediatric liver transplant recipientsLiver Transplantation and Surgery, 1999
- Prophylaxis against Herpes Infections in Kidney Transplant Patients with Special Emphasis on CMVScandinavian Journal of Infectious Diseases, 1998
- Two grams daily of oral acyclovir reduces the incidence of cytomegalovirus disease in CMV-seropositive liver transplant recipientsTransplant International, 1997
- Prophylaxis of acute gastroduodenal bleeding after renal transplantationTransplant International, 1997
- Herpes simplex esophagitis after renal transplantationTransplant International, 1994
- Pancreatitis in Patients with End-Stage Renal DiseaseMedicine, 1994
- OmeprazoleNew England Journal of Medicine, 1991
- TREATMENT OF INVASIVE CYTOMEGALOVIRUS DISEASE IN SOLID ORGAN TRANSPLANT PATIENTS WITH GANCICLOVIRTransplantation, 1991
- Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low‐dose methotrexateArthritis & Rheumatism, 1989